What is Weakness?
 

Weakness is a reduction in maximum voluntary muscle strength. True muscle weakness should be distinguished from fatigue or asthenia, in which a person feels weak or lacks energy despite having relatively preserved muscle strength.

Primary Causes of Weakness
 

• Myopathies: Inflammatory myopathies (polymyositis, dermatomyositis), muscular dystrophies, toxic/drug-induced myopathies (statins, corticosteroids), and metabolic myopathies.

• Neuropathies: Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy (CIDP), diabetic neuropathy, and mononeuropathies.

• Motor Neuron Diseases: Amyotrophic Lateral Sclerosis (ALS), primary lateral sclerosis, and spinal muscular atrophies.

• Neuromuscular Junction Disorders: Myasthenia Gravis and Lambert-Eaton myasthenic syndrome.

• Musculoskeletal Pathologies: Osteoarthritis, inflammatory arthritis, tendonitis, muscle strains, or disuse atrophy.

Secondary Causes of Weakness
 

• Central Nervous System (CNS) Pathology: Stroke (cerebrovascular accident), transient ischemic attack (TIA), multiple sclerosis, spinal cord compression, and intracranial masses.

• Electrolyte & Metabolic Disturbances: Hypokalemia, hyperkalemia, hypocalcemia, hyponatremia, severe hypomagnesemia, and uremia.

• Endocrine & Systemic Disorders: Hypothyroidism, hyperthyroidism, Addison's disease, uncontrolled diabetes mellitus, and chronic organ failure (hepatic, renal, or cardiac).

• Nutritional & Hematologic Deficiencies: Severe anemia, vitamin B12 deficiency, folate deficiency, and general protein-energy malnutrition.

• Infectious & Inflammatory States: Sepsis, chronic infections (e.g., HIV, post-viral fatigue), and systemic autoimmune conditions (e.g., systemic lupus erythematosus).

• Medication-Induced Weakness: Adverse effects from statins, beta-blockers, corticosteroids, chemotherapy agents, or prolonged neuromuscular blockade.

Diagnostics
 

• Clinical History & Physical Examination: Onset (acute vs. chronic), distribution, associated sensory changes, and manual muscle testing (MRC scale 0–5).

• Laboratory Testing:

  • Complete blood count (CBC) and inflammatory markers (ESR, CRP).

  • Comprehensive metabolic panel (electrolytes, renal, and hepatic function).

  • Thyroid-stimulating hormone (TSH) and free T4.

  • Creatine kinase (CK) to evaluate for muscle breakdown.

  • Vitamin B12, folate, and iron panels.

  • Autoimmune and specialized serologies (e.g., acetylcholine receptor antibodies, ANA).

• Electrodiagnostic Studies: Electromyography (EMG) and nerve conduction studies (NCS) to differentiate myopathic from neurogenic disorders.

• Imaging Diagnostics: Magnetic Resonance Imaging (MRI) of the brain, spinal cord, or targeted muscle groups.

• Invasive Diagnostics: Lumbar puncture (cerebrospinal fluid analysis) or muscle/nerve biopsies when indicated.
   

Management 
 

Non-Pharmacological Management: physical & occupational therapy, nutritional support, assistive devices (canes, walkers, wheelchairs) and home safety modifications to prevent falls, neurology referral

Pharmacotherapy
 

When Is Weakness an Emergency?
 

• Sudden weakness or numbness on one side of the body, particularly with facial drooping, difficulty speaking, vision changes, severe dizziness, or difficulty walking

• Sudden or rapidly progressive weakness

• New weakness accompanied by loss of bladder or bowel control or saddle numbness

• Weakness associated with difficulty breathing or swallowing

• Severe weakness associated with confusion, loss of consciousness, or other significant neurological symptoms

                                                      References & Guidelines
 

• American Academy of Family Physicians (AAFP). Muscle Weakness in Adults: Evaluation and Differential Diagnosis.

• Merck Manual Professional Edition. Weakness.

• National Institute of Neurological Disorders and Stroke (NINDS). Neurological Disorders and Conditions Associated With Muscle Weakness.

• American Academy of Neurology (AAN). Clinical guidance for neuromuscular and neurological disorders associated with weakness.

​